NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

Clinical trial NCT06299163 · TERMINATED

Trial details

NCT number: NCT06299163
Sponsor: Numab Therapeutics AG
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Carcinoma Fallopian Tube Carcinoma Peritoneal Carcinoma Endometrial Cancer Adenocarcinoma of Lung Triple Negative Breast Cancer Liposarcoma Leiomyosarcoma Mesothelioma, Malignant Adenocarcinoma - Gastroesophageal Junction (GEJ)Adenocarcinoma of the Stomach Melanoma, Malignant

Start date: 2024-05-01
Primary completion: 2025-04-18
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.